Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 6.131E-11 | 1.027E-07 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 2.011E-09 | 2.737E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 1.574E-08 | 1.653E-05 | CYP1A2, CYP2C19, CYP2C9, CYP3A4, NQO2, PTGS1 |
BP | GO:0065007; biological regulation | GO:0098771; inorganic ion homeostasis | 2.617E-07 | 2.110E-04 | APP, CA12, CA2, CA7, ESR1, HIF1A, HTT, PIK3CB, TP53 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 3.625E-07 | 2.442E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 6.633E-07 | 3.801E-04 | CYP1A2, CYP2C9, CYP3A4 |
BP | Unclassified; | GO:0032846; positive regulation of homeostatic process | 9.105E-07 | 4.836E-04 | CA2, CA7, HIF1A, HTT, PIK3CB, PTGS2 |
BP | GO:0065007; biological regulation | GO:0030003; cellular cation homeostasis | 1.306E-06 | 6.772E-04 | APP, CA2, CA7, ESR1, HIF1A, HTT, PIK3CB, TP53 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.527E-06 | 7.559E-04 | APP, CYP1A2, CYP2C19, CYP2C9, CYP3A4, ESR1 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.900E-25 | 2.069E-21 | CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.191E-03 | 7.880E-03 | CYP1A2; CYP3A4 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 7.230E-03 | 1.508E-02 | CYP1A2 |
hsa00340 | Histidine metabolism_Homo sapiens_hsa00340 | 3.425E-02 | 4.583E-02 | MAOA |
hsa00360 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.438E-02 | 3.470E-02 | MAOA |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.530E-03 | 4.409E-03 | MAOA; CYP1A2 |
hsa00562 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 4.742E-03 | 1.083E-02 | PIK3CA; PIK3CB |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.876E-06 | 2.837E-05 | CYP2C9; CYP2C19; PTGS2; PTGS1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 8.255E-08 | 2.497E-06 | CYP2C9; CYP1A2; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.127E-04 | 7.136E-04 | CYP2C9; CYP1A2; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.753E-32 | 4.541E-30 | CA12; CA1; CA3; CA5B; CA2; CA5A; CA4; CA7; CA6; CA9; CA14; CA13 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Trematode infection | B66.9 | ESR1 |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Neuroendocrine cancer | C7A | SLC6A2 |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | PTGS2 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A; CA9 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; ESR1; ESR1; NQO2 |
C00-D49: Neoplasms | Brain cancer | C71, D33 | ESR1 |
C00-D49: Neoplasms | Cancer | C00-C96 | PTGS2; HIF1A; TP53; PIK3CA; PIK3CB; CA1; CA9; ESR1; ESR1; NQO2; APP |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A; TP53; PIK3CA; PIK3CB; CA9 |